US Broker Ratings

Alcon Inc. (ALC) Stock Analysis: Unveiling a 27.83% Potential Upside in the Eye Care Giant

Alcon Inc. (ALC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing investor attention with its promising potential upside of 27.83%. Based..

Solventum Corporation (SOLV) Stock Analysis: Unlocking a 36% Upside Potential in Healthcare

Investors seeking opportunities amid the dynamic landscape of the healthcare sector might find Solventum Corporation (SOLV) an intriguing prospect. Despite recent market fluctuations, the company stands out with a potential..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Highlights 22% Upside Potential Amidst Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been catching the eye of investors in the biotechnology sector, particularly those with a focus on companies engaged in cutting-edge healthcare solutions. With a..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 29% Potential Upside with Strong Analyst Ratings

AptarGroup, Inc. (NYSE: ATR) stands as a formidable player in the healthcare sector, more specifically within the medical instruments and supplies industry. With its headquarters in Crystal Lake, Illinois, AptarGroup..

Globus Medical, Inc. (GMED) Stock Analysis: Unveiling a 25% Potential Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector, is capturing investor attention with a promising 25.21% potential upside, as highlighted by the average target price from..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 10.54% Potential Upside in the Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a key player in the medical instruments and supplies industry, offers a unique investment opportunity amidst the complexities of the healthcare sector. With a market capitalization..

Waters Corporation (WAT) Stock Analysis: Unpacking a 29.22% Potential Upside for Investors

Waters Corporation (NYSE: WAT) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $29.85 billion, the company has..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 38.91% Potential Upside for Savvy Investors

Tenet Healthcare Corporation (NYSE: THC) stands out in the healthcare sector with a robust market capitalization of $16.54 billion. As a key player in the medical care facilities industry, Tenet..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Unpacking a 34.89% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) stands at the forefront of the biotechnology sector, carving a niche in the precision oncology space with its innovative approach to targeting RAS-addicted cancers. This..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Challenges with Biotechnology’s Innovator

Moderna, Inc. (NASDAQ: MRNA) has been a focal point in the biotechnology sector, especially during the COVID-19 pandemic, where it emerged as a central player with its mRNA vaccine. However,..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 26.67% Potential Upside in Healthcare

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Its 5.83% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (RDY) has long established itself as a formidable player in the global pharmaceutical landscape. With a market capitalization of $11.12 billion, this India-based healthcare giant operates..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the Healthcare Giant’s 0.71% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a behemoth in the healthcare sector, continues to capture the attention of investors with its robust product portfolio and significant market cap of $187.56 billion. As..

Novartis AG (NVS) Stock Analysis: Evaluating the 3.08% Dividend Yield and Growth Prospects

Novartis AG (NVS), a Swiss-based healthcare giant, continues to make headlines in the pharmaceutical industry with a robust market cap of $297.32 billion. As a leading player in the drug..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 26% Upside Potential in the Healthcare Sector

Investors intrigued by the healthcare sector may find Ascendis Pharma A/S (NASDAQ: ASND) an attractive opportunity, especially with a forecasted potential upside of 26.41%. This Denmark-based biotechnology company, with a..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 31.84% Potential Upside for Investors

HealthEquity, Inc. (NASDAQ: HQY) stands as a key player in the healthcare sector, specifically within the health information services industry. Based in Draper, Utah, HealthEquity provides a technology-enabled service platform..

Natera, Inc. (NTRA) Investor Outlook: Exploring 24.58% Potential Upside with Strong Buy Ratings

Natera, Inc. (NTRA), a prominent player in the Healthcare sector specializing in Diagnostics & Research, continues to attract investor attention with its cutting-edge molecular testing services. Headquartered in Austin, Texas,..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 31% Potential Upside Amid Strong Revenue Growth

CVS Health Corporation (NYSE: CVS), a formidable player in the healthcare sector, is capturing investor attention with a striking 31.21% potential upside, according to recent analyst ratings. This potential, coupled..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Giant with 83.30% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) is garnering significant attention in the investment community, not least because of its notable potential upside of 83.30%. With a market capitalization of $3.75 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds